Should cell‐free DNA testing be used in pregnancy with increased fetal nuchal translucency?-Reference-Cited by-同舟云学术

Should cell‐free DNA testing be used in pregnancy with increased fetal nuchal translucency?

Published:2020-04-07 Issue:5 Volume:55 Page:645-651
ISSN:0960-7692
Container-title:Ultrasound in Obstetrics & Gynecology
language:en
Short-container-title:Ultrasound Obstet Gynecol

Author:

Miranda J.¹²^ORCID,Paz y Miño F.¹²,Borobio V.¹²,Badenas C.³⁴,Rodriguez‐Revenga L.³⁴,Pauta M.⁵^ORCID,Borrell A.¹²⁴^ORCID

Affiliation:

1. Fetal i+D Fetal Medicine Research, BCNatal, Barcelona Center for Maternal‐Fetal and Neonatal Medicine, Hospital Clínic and Hospital Sant Joan de Deu, Institut Clinic de Ginecologia, Obstetricia i Neonatologia, IDIBAPSUniversity of Barcelona Barcelona Catalonia Spain

2. Center for Biomedical Research on Rare Diseases (CIBER‐ER) Madrid Spain

3. Biomedical Diagnostic Center, Hospital Clinic de Barcelona, IDIBAPS Barcelona Catalonia Spain

4. CIBER de Enfermedades RarasInstituto de Salud Carlos III Madrid Spain

5. BCNatal, Barcelona Center for Maternal‐Fetal and Neonatal Medicine, Hospital Clínic and Hospital Sant Joan de DeuInstitut Clinic de Ginecologia, Obstetricia i Neonatologia Barcelona Catalonia Spain

Publisher

Wiley

Subject

Obstetrics and Gynecology,Radiology, Nuclear Medicine and imaging,Reproductive Medicine,General Medicine,Radiological and Ultrasound Technology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/uog.20397

Reference37 articles.

1. Using fetal nuchal translucency to screen for major congenital cardiac defects at 10-14 weeks of gestation: population based cohort study

2. First-Trimester or Second-Trimester Screening, or Both, for Down's Syndrome

3. Risk of selected structural abnormalities in infants after increased nuchal translucency measurement

4. Screening for fetal aneuploidies at 11 to 13 weeks

5. First-trimester screening for trisomy 21 combining biochemistry and ultrasound at individually optimal gestational ages. An interventional study

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Advancing fetal diagnosis and prognostication using comprehensive prenatal phenotyping and genetic testing;Pediatric Research;2024-06-27

2. First-Trimester Ultrasound Screening in Routine Obstetric Practice;Obstetrics & Gynecology;2024-06

3. Can Cell-Free DNA Testing Suffice for Isolated Fetal Nuchal Translucency Between the 95th – 99th Centile? A Retrospective Analysis in A Centre in North India;2024-04-05

4. Associations between genomic aberrations, increased nuchal translucency, and pregnancy outcomes: a comprehensive analysis of 2,272 singleton pregnancies in women under 35;Frontiers in Medicine;2024-04-03

5. Perinatal Outcomes in Foetuses with Increased Nuchal Translucency and Normal Karyotype: A Retrospective Cohort Study from the United Arab Emirates;Journal of Clinical Medicine;2023-10-04